• Ownership

Scott Myers - Insider Trading & Ownership

Entity
Individual
Location
C/O Cascadian Therapeutics, Inc., 3101 Western Ave., Suite 600, Seattle, WA
Summary
The estimated net worth of Scott Myers is at least $6.63M dollars as of November 13, 2024. Scott Myers is the Chief Executive Officer, Director of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $5.45M. Scott Myers is the Director of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $827K. Scott Myers is the Director of DYNAVAX TECHNOLOGIES CORP and owns shares of DYNAVAX TECHNOLOGIES CORP (DVAX) stock worth about $290K. Scott Myers is the Director of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. stock worth about $64.4K.
All Insider Reports
All Insider Reports

Ownership of Scott Myers

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VRDN Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director $5.45M Apr 12, 2023
ZNTL Zentalis Pharmaceuticals, Inc. Director $827K Nov 13, 2024
DVAX DYNAVAX TECHNOLOGIES CORP Director $290K May 23, 2024
HARP Harpoon Therapeutics, Inc. Director $64.4K Mar 11, 2024
RNAC Cartesian Therapeutics, Inc. Director Nov 13, 2023
TRIL Trillium Therapeutics Inc. Director Nov 17, 2021

Insider Transactions Reported by Scott Myers:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.